Investigation Overview
Nov. 2, 2012 (Shareholders Foundation) -- An investigation on behalf of investors of Keryx Biopharmaceuticals (NASDAQ:KERX) shares over potential securities laws violations by Keryx Biopharmaceuticals and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of...
You must register (for free) or login to view the entire investigation.